No. |
Group |
Type |
Drug ID |
Drug Name |
SMILES ⇨ TargetHunter |
Image |
1 |
Experimental |
SmallMoleculeDrug |
DB08028 |
BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE |
|
 |
2 |
Experimental |
SmallMoleculeDrug |
DB03622 |
2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione |
|
 |
3 |
Experimental |
SmallMoleculeDrug |
DB07397 |
(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide |
|
 |
4 |
Experimental |
SmallMoleculeDrug |
DB08476 |
3-AMINO-AZACYCLOTRIDECAN-2-ONE |
|
 |
5 |
Experimental |
SmallMoleculeDrug |
DB03636 |
Glycinamid |
|
 |
6 |
Experimental |
SmallMoleculeDrug |
DB02326 |
1-Hydroxyamine-2-Isobutylmalonic Acid |
|
 |
7 |
Experimental |
SmallMoleculeDrug |
DB03207 |
2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid |
|
 |
8 |
Experimental |
SmallMoleculeDrug |
DB07772 |
(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid |
|
 |
9 |
Experimental |
SmallMoleculeDrug |
DB08403 |
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID |
|
 |
10 |
Experimental |
SmallMoleculeDrug |
DB02953 |
2-Thiomethyl-3-Phenylpropanoic Acid |
|
 |
11 |
Experimental |
SmallMoleculeDrug |
DB06971 |
N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA |
|
 |
12 |
Experimental |
SmallMoleculeDrug |
DB07900 |
3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE |
|
 |
13 |
Experimental |
SmallMoleculeDrug |
DB07713 |
(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid |
|
 |
14 |
Experimental |
SmallMoleculeDrug |
DB03880 |
Batimastat |
|
 |
15 |
Approved; Investigational |
SmallMoleculeDrug |
DB00786 |
Marimastat |
|
 |
No. |
Group |
Type |
Drug ID |
Drug Name |
SMILES ⇨ TargetHunter |
Image |
Confidence score |
1 |
Approved; Nutraceutical |
SmallMoleculeDrug |
DB00157 |
NADH |
|
 |
41.0%
|
2 |
Experimental |
SmallMoleculeDrug |
DB08489 |
N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE |
|
 |
30.0%
|
3 |
Approved |
SmallMoleculeDrug |
DB00201 |
Caffeine |
|
 |
29.1%
|
4 |
Approved; Withdrawn |
SmallMoleculeDrug |
DB11148 |
Butamben |
|
 |
26.3%
|
5 |
Experimental |
SmallMoleculeDrug |
DB03439 |
4,6-dideoxy-4-amino-alpha-D-glucose |
|
 |
25.4%
|
6 |
Approved; Investigational |
SmallMoleculeDrug |
DB11633 |
Isavuconazole |
|
 |
24.5%
|
7 |
Experimental |
SmallMoleculeDrug |
DB08170 |
(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE |
|
 |
24.2%
|
8 |
Experimental; Investigational |
SmallMoleculeDrug |
DB04216 |
Quercetin |
|
 |
23.2%
|
9 |
Withdrawn |
SmallMoleculeDrug |
DB07931 |
Hexestrol |
|
 |
22.2%
|
10 |
Approved; Nutraceutical; Vet approved |
SmallMoleculeDrug |
DB00162 |
Vitamin A |
|
 |
22.1%
|
11 |
Approved; Investigational |
SmallMoleculeDrug |
DB00234 |
Reboxetine |
|
 |
21.4%
|
12 |
Approved; Nutraceutical |
SmallMoleculeDrug |
DB00134 |
Methionine |
|
 |
21.4%
|
13 |
Approved; Investigational |
SmallMoleculeDrug |
DB03088 |
Pidolic Acid |
|
 |
21.4%
|
14 |
Approved |
SmallMoleculeDrug |
DB09283 |
Trapidil |
|
 |
21.3%
|
15 |
Experimental |
SmallMoleculeDrug |
DB07768 |
(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE |
|
 |
20.9%
|
16 |
Experimental |
SmallMoleculeDrug |
DB07821 |
(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate |
|
 |
20.5%
|
17 |
Experimental |
SmallMoleculeDrug |
DB08493 |
5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID |
|
 |
20.2%
|
18 |
Approved; Investigational |
BiotechDrug |
DB05829 |
Parathyroid hormone |
|
 |
19.7%
|
19 |
Approved |
SmallMoleculeDrug |
DB00381 |
Amlodipine |
|
 |
19.5%
|
20 |
Approved |
SmallMoleculeDrug |
DB00898 |
Ethanol |
|
 |
18.9%
|
|